Acrospire Investment Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-40	Closed	-$3K	–	2267
2016 Q3	$3K	Buy	40 +15	+60%	+$1.13K	﹤0.01%	1881
2016 Q2	$2K	Buy	+25	New	+$2K	﹤0.01%	1944